Posted in | News

UPM to Close Pulp Mill in Q1 2009

Jan 14 2009

Related Stories

UPM's associated company Oy Metsä-Botnia Ab has today announced the permanent closure of the Kaskinen pulp mill during the first quarter of 2009. The special charges resulting from the closure will reduce UPM's associated company results by approximately EUR 27 million in the first quarter of 2009.

The annual pulp production capacity of the Kaskinen mill is 450,000 tonnes of mainly hardwood pulp. UPM's share of the capacity according to its ownership is roughly 212,000 tonnes. The pulp produced at Kaskinen mill has not been used in UPM's paper production. After the closure of the Kaskinen mill, UPM's calculatory annual pulp production capacity will be 3.6 million tonnes.

UPM's share in Botnia is 47 percent.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback